Reflection Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Reflection Asset Management's VRTX Position: Q3 2026 in Review
Reflection Asset Management held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2026 at 454 shares worth $237K. The position accounts for 0.1% of the portfolio, ranked #135.
Reflection Asset Management first reported a position in VRTX in Q4 2025 and has held it in 3 quarters since. 1,793 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Reflection Asset Management held 454 shares of Vertex Pharmaceuticals worth $237K as of Q3 2026.
- Reflection Asset Management left its Vertex Pharmaceuticals share count unchanged in Q3 2026.
- Vertex Pharmaceuticals made up 0.1% of Reflection Asset Management's portfolio in Q3 2026, its #135 holding.
- Reflection Asset Management first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- 1,793 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Reflection Asset Management's 13F filing for Q3 2026, filed 28 Oct 2026.